In summary, this systematic review and meta-analysis elucidate that tumoral overexpression of CXCR4 in 1381 patients represents a promising prognostic factor, resulting in significantly shortened overall survival as well as disease-free survival in colorectal cancer patients. Here, CXCR4 is linked to colorectal cancer.